179 related articles for article (PubMed ID: 23876410)
21. Perivascular epithelioid cell tumour: dynamic CT, MRI and clinicopathological characteristics--analysis of 32 cases and review of the literature.
Tan Y; Zhang H; Xiao EH
Clin Radiol; 2013 Jun; 68(6):555-61. PubMed ID: 23245276
[TBL] [Abstract][Full Text] [Related]
22. Clinical implication of small (<20 mm) enhancing hepatic nodules observed only during three-dimensional gadobenate dimeglumine-enhanced hepatic arterial-phase MRI of the hepatitis B virus-induced mild cirrhosis.
Kim YK; Lee YH; Kwak HS; Kim CS; Han YM
Clin Imaging; 2008; 32(6):453-9. PubMed ID: 19006774
[TBL] [Abstract][Full Text] [Related]
23. Mammary-type myofibroblastoma of the liver: multi-modality imaging features with histopathologic correlation.
Millo NZ; Yee EU; Mortele KJ
Abdom Imaging; 2014 Jun; 39(3):482-7. PubMed ID: 24463957
[TBL] [Abstract][Full Text] [Related]
24. [Dynamic contrast-enhanced MR imaging and digital subtraction angiography manifestation of hepatic focal nodular hyperplasia].
Zhou JX; Li Y; Hong GB; Luo JH; Chen YT; Xu LF; Liang BL
Ai Zheng; 2008 Nov; 27(11):1186-9. PubMed ID: 19000451
[TBL] [Abstract][Full Text] [Related]
25. Inflammatory myofibroblastic tumour of the maxillary sinus: CT and MRI findings.
Yuan XP; Li CX; Cao Y; Singh S; Zhong R
Clin Radiol; 2012 Dec; 67(12):e53-7. PubMed ID: 22974570
[TBL] [Abstract][Full Text] [Related]
26. Characteristic CT and MRI findings of intracranial chondroma.
Duan F; Qiu S; Jiang J; Chang J; Liu Z; Lv X; Feng X; Xiong W; An J; Chen J; Yang W; Wen C
Acta Radiol; 2012 Dec; 53(10):1146-54. PubMed ID: 22983260
[TBL] [Abstract][Full Text] [Related]
27. Contrast enhanced liver MRI in patients with primary sclerosing cholangitis: inverse appearance of focal confluent fibrosis on delayed phase MR images with hepatocyte specific versus extracellular gadolinium based contrast agents.
Husarik DB; Gupta RT; Ringe KI; Boll DT; Merkle EM
Acad Radiol; 2011 Dec; 18(12):1549-54. PubMed ID: 21958599
[TBL] [Abstract][Full Text] [Related]
28. Inflammatory myofibroblastic tumor and low-grade myofibroblastic sarcoma: a comparative study of clinicopathologic features and further observations on the immunohistochemical profile of myofibroblasts.
Qiu X; Montgomery E; Sun B
Hum Pathol; 2008 Jun; 39(6):846-56. PubMed ID: 18400254
[TBL] [Abstract][Full Text] [Related]
29. [Study of the liver and the portal venous system with digital rotational angiography].
Gattoni F; Dova S; Tonolini M; Uslenghi CM
Radiol Med; 2001 Mar; 101(3):118-24. PubMed ID: 11402948
[TBL] [Abstract][Full Text] [Related]
30. Real-time contrast-enhanced ultrasonography of resected and immunohistochemically proven hepatic angiomyolipomas.
Li R; Zhang X; Hua X; Cai P; Zhong H; Guo Y; Ding S; Yan X
Abdom Imaging; 2010 Dec; 35(6):676-82. PubMed ID: 20020286
[TBL] [Abstract][Full Text] [Related]
31. Dynamic enhancement pattern of HCC smaller than 3 cm in diameter on gadoxetic acid-enhanced MRI: comparison with multiphasic MDCT.
Park VY; Choi JY; Chung YE; Kim H; Park MS; Lim JS; Kim KW; Kim MJ
Liver Int; 2014 Nov; 34(10):1593-602. PubMed ID: 24673802
[TBL] [Abstract][Full Text] [Related]
32. HCC-to-liver contrast on arterial-dominant phase images of EOB-enhanced MRI: comparison with dynamic CT.
Kanata N; Yoshikawa T; Ohno Y; Kanda T; Uchida K; Izaki K; Fukumoto T; Ku Y; Itoh T; Kitajima K; Takahashi S; Sugimura K
Magn Reson Imaging; 2013 Jan; 31(1):17-22. PubMed ID: 22898685
[TBL] [Abstract][Full Text] [Related]
33. [Characterization of focal liver lesions with contrast-enhanced low MI real time ultrasound and SonoVue].
Hohmann J; Skrok J; Puls R; Albrecht T
Rofo; 2003 Jun; 175(6):835-43. PubMed ID: 12811698
[TBL] [Abstract][Full Text] [Related]
34. Inflammatory myofibroblastic tumor of the liver: a case report.
Sürer E; Bozova S; Gökhan GA; Gürkan A; Elpek GO
Turk J Gastroenterol; 2009 Jun; 20(2):129-34. PubMed ID: 19530046
[TBL] [Abstract][Full Text] [Related]
35. Myofibroblastic tumours: neoplasias with divergent behaviour. Ultrastructural and flow cytometric analysis.
Biselli R; Boldrini R; Ferlini C; Boglino C; Inserra A; Bosman C
Pathol Res Pract; 1999; 195(9):619-32. PubMed ID: 10507082
[TBL] [Abstract][Full Text] [Related]
36. Inflammatory myofibroblastic tumors of the urinary tract: a clinicopathologic study of 46 cases, including a malignant example inflammatory fibrosarcoma and a subset associated with high-grade urothelial carcinoma.
Montgomery EA; Shuster DD; Burkart AL; Esteban JM; Sgrignoli A; Elwood L; Vaughn DJ; Griffin CA; Epstein JI
Am J Surg Pathol; 2006 Dec; 30(12):1502-12. PubMed ID: 17122505
[TBL] [Abstract][Full Text] [Related]
37. MRI characterization of inflammatory myofibroblastic tumors in the maxillofacial region.
Li H; Wang de L; Liu XW; Geng ZJ; Xie CM
Diagn Interv Radiol; 2014; 20(4):310-5. PubMed ID: 24808436
[TBL] [Abstract][Full Text] [Related]
38. Imaging features of subcentimeter hypointense nodules on gadoxetic acid-enhanced hepatobiliary phase MR imaging that progress to hypervascular hepatocellular carcinoma in patients with chronic liver disease.
Jang KM; Kim SH; Kim YK; Choi D
Acta Radiol; 2015 May; 56(5):526-35. PubMed ID: 24838304
[TBL] [Abstract][Full Text] [Related]
39. Metastatic liver tumor from cystic ovarian carcinomas: CT and MRI appearance.
Tang Y; Yamashita Y; Ogata I; Namimoto T; Abe Y; Urata J; Takahashi M
Radiat Med; 1999; 17(4):265-70. PubMed ID: 10510898
[TBL] [Abstract][Full Text] [Related]
40. Enhancement patterns of focal liver masses: discordance between contrast-enhanced sonography and contrast-enhanced CT and MRI.
Wilson SR; Kim TK; Jang HJ; Burns PN
AJR Am J Roentgenol; 2007 Jul; 189(1):W7-W12. PubMed ID: 17579140
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
